Enhabit, Inc.
Enhabit, Inc. (EHAB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EHAB · as of Jun 8, 2026
Key Statistics
Explore Enhabit, Inc. Data
ehab stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 18.2%
The EHAB analyst consensus is Hold, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $13.53, representing -1.96% downside from the current price of $13.80.
Competitors & Peers
ehab competitorsEHAB
AGL
AUNA
AUTL
CBLL
CCRNStock Performance
Full HistoryAbout Enhabit, Inc.
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitati…
what is enhabit, inc. · ehab stock overview · enhabit, inc. company profile · who is enhabit, inc. ceo · ehab NYSE · enhabit, inc. headquarters · enhabit, inc. business segments
About Stock Overview & Key Data
Enhabit, Inc. (EHAB) is a Healthcare company in the Medical - Care Facilities industry, listed on NYSE since Jun 23, 2022. As of the latest trading session, EHAB stock price is $13.80, with a market capitalization of $706.9M. The stock has returned +28.01% over the past 12 months and +49.67% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Enhabit, Inc. stock is Hold, with an average 12-month price target of $13.53. In fiscal year 2025, Enhabit, Inc. reported revenue of $1.1B and net income of -$4.6M. For detailed data — including Enhabit, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Enhabit, Inc. (EHAB) stock price is $13.80. The stock is traded on NYSE under the ticker symbol EHAB. The 52-week range is $6.47 – $14.22.